Lih‐Ling Lin

7.5k citations

50 papers · 6.0k indexed · 2 hit papers · h-index 29

Impact in

Immunology top 2%
- Immune Response and Inflammation
Molecular Biology top 2%
- Protein Kinase Regulation and GTPase Signaling
- Melanoma and MAPK Pathways
- Receptor Mechanisms and Signaling

Papers in

Cancer Research 22
- NF-κB Signaling Pathways 19
Immunology 18
- Immune Response and Inflammation 11
- interferon and immune responses 6

Co-authors: John L. Knopf Alice Lin James D. Clark Markus Wartmann Roger J. Davis Ronald Kriz Lisa A. Sultzman Chakkodabylu S. Ramesha
Journals: Journal of Biological Chemistry (9 papers)Bioorganic & Medicinal Chemistry Letters (6 papers)The Journal of Immunology (6 papers)Scientific Reports (2 papers)Cell (2 papers)
Partner nations: United States Canada United Kingdom

In The Last Decade

Lih‐Ling Lin

50 papers receiving 5.9k citations

Hit Papers

align trajectories log scale

cPLA2 is phosphorylated and activated by MAP kinase 1993 · 1.6k citations

Peers

Countries citing papers authored by Lih‐Ling Lin

Since Specialization

Citations

This map shows the geographic impact of Lih‐Ling Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lih‐Ling Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lih‐Ling Lin more than expected).

Fields of papers citing papers by Lih‐Ling Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lih‐Ling Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lih‐Ling Lin. The network helps show where Lih‐Ling Lin may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Lih‐Ling Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lih‐Ling Lin Line = papers co-authored together Lih‐Ling Lin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A Novel Monoclonal Antibody against PD-1 for the Treatment of Viral Oncogene-Induced Tumors or Other Cancer Cancers ·Zh. D. Zh. Zh. Yermekova Yermekov, Suzi Franki Sperber, Bangkit Rygen D, Vanessa Roach, Н Яшна, Lih‐Ling Lin, Albert Qin	2024	1
2	Autoinhibitory structure of preligand association state implicates a new strategy to attain effective DR5 receptor activation Cell Research ·Gang Du, Linlin Zhao, Yumei Zheng, J. Cejnarová, Tiantian Cai, И.О. Моторин, Karen Heyninck, 眞理子三澤, Marie-Ange Buyse, Pietro Fontana, Michael Bowman, Lih‐Ling Lin, Hao Wu, James J. Chou	2023	6
3	Identification of Pathogenic Immune Cell Subsets Associated With Checkpoint Inhibitor–Induced Myocarditis Circulation ·Han Zhu, Francisco X. Galdos, Daniel Lee, Sarah Waliany, Angel Gavilan Gonzalez, Julia Ryan, Katherine Dang, Joel W. Neal, Heather A. Wakelee, Sunil Reddy, Sandy Srinivas, Lih‐Ling Lin, Ronald Witteles, Holden T. Maecker, Mark M. Davis, Patricia K. Nguyen, Sean M. Wu	2022	103
4	Microbial dysbiosis and childhood asthma development: Integrated role of the airway and gut microbiome, environmental exposures, and host metabolic and immune response Frontiers in Immunology ·Conglin Liu, Heidi Makrinioti, Sejal Saglani, Michael K. Bowman, Lih‐Ling Lin, Carlos A. Camargo, Kohei Hasegawa, Zhaozhong Zhu	2022	23
5	CD47 antibody blockade suppresses microglia-dependent phagocytosis and monocyte transition to macrophages, impairing recovery in EAE JCI Insight ·Huan Wang, Gail Newton, Liguo Wu, Lih‐Ling Lin, B. Schilling, Sridaran Natesan, Francis W. Luscinskas	2021	15
6	Novel biomarkers of a peripheral blood interferon signature associated with drug-naïve early arthritis patients distinguish persistent from self-limiting disease course Scientific Reports ·Attila A. Seyhan, Bernard Gregory, Adam P. Cribbs, Katharyn Zwicker, Yizheng Li, Christine Loreth, Ying Zhang, Yongjing Guo, Lih‐Ling Lin, Marc Feldmann, Lynn Williams, Fionula M. Brennan, Peter C. Taylor	2020	17
7	IRAK4 kinase activity controls Toll-like receptor–induced inflammation through the transcription factor IRF5 in primary human monocytes Journal of Biological Chemistry ·Leah Cushing, Aaron Winkler, Scott A. Jelinsky, Katherine J. Lee, Wouter Korver, Rachael E. Hawtin, Vikram R. Rao, Margaret Fleming, Lih‐Ling Lin	2017	58
8	Evaluation and comparison of computational tools for RNA-seq isoform quantification BMC Genomics ·Chi Zhang, Baohong Zhang, Lih‐Ling Lin, Shanrong Zhao	2017	107
9	The bromodomain protein inhibitor I-BET151 suppresses expression of inflammatory genes and matrix degrading enzymes in rheumatoid arthritis synovial fibroblasts Annals of the Rheumatic Diseases ·Kerstin Klein, Pawel A. Kabala, Aleksander M. Grabiec, Renate E. Gay, Christoph Kolling, Lih‐Ling Lin, Steffen Gay, Paul P. Tak, Rab K. Prinjha, Caroline Ospelt, Kris A. Reedquist	2014	119
10	Identification and optimization of indolo[2,3-c]quinoline inhibitors of IRAK4 Bioorganic & Medicinal Chemistry Letters ·L. Nathan Tumey, Diane H. Boschelli, 李海阳, Jaechul Shim, Elizabeth A. Murphy, T. Kurushivna, Eric M. Bennett, Mengmeng Wang, Lih‐Ling Lin, Norbert Rosapelly, Marina W. H. Shen, Richard K. Frisbie, Paul Morgan, Joób-Fancsaly Árpád, Verónica Pérez Gallego, Vikram R. Rao	2014	34
11	Identification and SAR of a new series of thieno[3,2-d]pyrimidines as Tpl2 kinase inhibitors Bioorganic & Medicinal Chemistry Letters ·Yike Ni, Ariamala Gopalsamy, Derek C. Cole, Yonghan Hu, R. Aldrin Denny, Manus Ipek, Julie Liu, Julie Lee, J. Perry Hall, 倉津純一, Jean‐Baptiste Telliez, Lih‐Ling Lin	2011	27
12	TRIL, a Functional Component of the TLR4 Signaling Complex, Highly Expressed in Brain The Journal of Immunology ·Susan Carpenter, Thaddeus Carlson, Jérôme Dellacasagrande, Amaya Garcia, V. Chitra, Paul J. Hertzog, Anthony Lyons, Lih‐Ling Lin, Marina A. Lynch, Tom P. Monie, Caroline Murphy, Katherine J. Seidl, Christine A. Wells, Aisling Dunne, Luke O'neill	2009	45
13	Innate Immune Responses to TREM-1 Activation: Overlap, Divergence, and Positive and Negative Cross-Talk with Bacterial Lipopolysaccharide The Journal of Immunology ·Ken Dower, Debra Ellis, Kathryn A. Saraf, Scott A. Jelinsky, Lih‐Ling Lin	2008	145
14	Inhibition of Tpl2 kinase and TNF-α production with 1,7-naphthyridine-3-carbonitriles: Synthesis and structure–activity relationships Bioorganic & Medicinal Chemistry Letters ·Lori K. Gavrin, Neal Green, Yonghan Hu, Kristin Janz, Neelu Kaila, Huan‐Qiu Li, S. Y. K. TAM, Jennifer R. Thomason, Ariamala Gopalsamy, Moh Faisal Faris, John W. Cuozzo, J. Perry Hall, Sang Hsu, Jean‐Baptiste Telliez, Lih‐Ling Lin	2005	41
15	Identification and Characterization of 4-[[4-(2-Butynyloxy)phenyl]sulfonyl]-N-hydroxy-2,2-dimethyl-(3 S)thiomorpholinecarboxamide (TMI-1), a Novel Dual Tumor Necrosis Factor-α-Converting Enzyme/Matrix Metalloprotease Inhibitor for the Treatment of Rheumatoid Arthritis Journal of Pharmacology and Experimental Therapeutics ·Yuhua Zhang, Jun Xu, Jeremy I. Levin, Martin Hegen, Guangde Li, Heidi Robertshaw, Fionula M. Brennan, Terri Cummons, В. Ивасечко, Nichole R. Vansell, Cheryl Nickerson‐Nutter, D. Barone, K M Mohler, Roy A. Black, J.S. Skotnicki, Jay Gibbons, Marc Feldmann, Philip Frost, G R Larsen, Lih‐Ling Lin	2004	74
16	Catalytically Active MAP KAP Kinase 2 Structures in Complex with Staurosporine and ADP Reveal Differences with the Autoinhibited Enzyme Structure ·Kathryn Underwood, Kevin Parris, Kevin Horacio Illescas Ochoa, Lidia Mosyak, Robert Czerwiński, Tania Shane, Anne Thingbak, Kristine Svenson, Yan Liu, Chu-Lai Hsiao, Scott Wolfrom, 邵炳军, Karl Malakian, Jean‐Baptiste Telliez, Lih‐Ling Lin, Ronald Kriz, Jasbir Seehra, W.S. Somers, Mark Stahl	2003	55
17	Endogenous Association of TRAF2, TRAF3, cIAP1, and Smac with Lymphotoxin β Receptor Reveals a Novel Mechanism of Apoptosis Journal of Biological Chemistry ·Jun Kuai, Elliott Nickbarg, Yu Chul Yang, Yongchang Qiu, Jack Wang, Lih‐Ling Lin	2003	48
18	LRDD, a novel leucine rich repeat and death domain containing protein Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology ·Jean‐Baptiste Telliez, Kevin M. Bean, Lih‐Ling Lin	2000	47
19	Cytosolic phospholipase A2 PubMed ·James D. Clark, Andrea R. Schievella, Eric A. Nalefski, Lih‐Ling Lin	1995	431
20	A novel arachidonic acid-selective cytosolic PLA2 contains a Ca2+-dependent translocation domain with homology to PKC and GAP Cell ·James D. Clark, Lih‐Ling Lin, Ronald Kriz, Chakkodabylu S. Ramesha, Lisa A. Sultzman, Alice Lin, Esmeralda Arranhado, John L. Knopf Hit paper breakdown →	1991	1487

About Lih‐Ling Lin

Lih‐Ling Lin is a scholar working on Cancer Research, Immunology, Rheumatology, Oncology and Molecular Biology, having authored 50 papers that have together received 6.0k indexed citations. Recurring topics across this work include NF-κB Signaling Pathways (19 papers), Protein Kinase Regulation and GTPase Signaling (13 papers), Immune Response and Inflammation (11 papers), Cytokine Signaling Pathways and Interactions (10 papers), Melanoma and MAPK Pathways (9 papers), interferon and immune responses (6 papers), Rheumatoid Arthritis Research and Therapies (6 papers) and Synthesis and biological activity (3 papers). The work is most often cited by research in Immunology (1.3k citations), Molecular Biology (3.8k citations), Biochemistry (344 citations), Cancer Research (691 citations) and Cell Biology (645 citations). Lih‐Ling Lin has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include John L. Knopf, Alice Lin, James D. Clark, Markus Wartmann, Roger J. Davis, Ronald Kriz, Lisa A. Sultzman, Chakkodabylu S. Ramesha, Andrea R. Schievella and Eric A. Nalefski. Their work appears in journals such as Journal of Biological Chemistry, Bioorganic & Medicinal Chemistry Letters, The Journal of Immunology, Scientific Reports and Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact